| Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections (NCT05060419) | Qilu Pharmaceutical Co., Ltd. | 2021-10-08 |
| Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults (NCT04882085) | Pfizer | 2021-08-26 |
| Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children (NCT04654507) | Hamad Medical Corporation | 2021-03-03 |
| Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis (NCT04686318) | University of Southern Denmark | 2021-03-01 |
| Clinical Characteristics of Acutely Hospitalized Adults With Acute Pyelonephritis (NCT04667195) | University of Southern Denmark | 2021-03-01 |
| Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis (NCT05674032) | Thomayer University Hospital | 2020-06-24 |
| Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections (NCT03840148) | Venatorx Pharmaceuticals, Inc. | 2019-08-07 |
| Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (NCT03788967) | Spero Therapeutics | 2019-06-03 |
| IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis (NCT03757234) | Paratek Pharmaceuticals Inc | 2018-11-19 |
| Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections (NCT03445195) | Entasis Therapeutics | 2018-01-17 |
| Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections (NCT02753946) | Nabriva Therapeutics AG | 2016-04-01 |
| A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) (NCT02486627) | Achaogen, Inc. | 2016-01-11 |
| Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP (NCT02166476) | Melinta Therapeutics, Inc. | 2014-11-20 |
| Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults (NCT02168946) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-07-01 |
| Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (NCT02420366) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-05-01 |
| CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (NCT03477422) | Venus Remedies Limited | 2014-01-11 |
| Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection (NCT02034851) | Institut Investigacio Sanitaria Pere Virgili | 2013-04-01 |
| Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis (NCT01928433) | MerLion Pharmaceuticals GmbH | 2012-12-01 |
| Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli (NCT02537847) | Mahidol University | 2012-11-01 |
| A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) (NCT01096849) | Achaogen, Inc. | 2010-07-13 |
| Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection (NCT04682834) | Iterum Therapeutics, International Limited | |